John Kaczmar to Protein Kinase Inhibitors
This is a "connection" page, showing publications John Kaczmar has written about Protein Kinase Inhibitors.
Connection Strength
0.106
-
The efficacy of ceritinib in patients with ALK-positive non-small cell lung cancer. Ther Adv Respir Dis. 2015 Oct; 9(5):236-41.
Score: 0.106
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.